The complex assessment of state and treatment results of patients with paranoid schizophrenia

Samoylova D.D.; Barylnik Yu.B.

doi:https://doi.org/10.17116/jnevro202112101159

Samoylova D.D.

Razumovsky Saratov State Medical University

Barylnik Yu.B.

Razumovsky Saratov State Medical University

The complex assessment of state and treatment results of patients with paranoid schizophrenia

Authors:

Samoylova D.D., Barylnik Yu.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(1): 59‑64

DOI: 10.17116/jnevro202112101159

Read: 2802 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Samoylova DD, Barylnik YuB. The complex assessment of state and treatment results of patients with paranoid schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(1):59‑64. (In Russ.)
https://doi.org/10.17116/jnevro202112101159

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To develop a scale of complex assessment of treatment outcomes based on the indicators of the traditionally used scales.

MATERIAL AND METHODS

A total of 420 patients with paranoid schizophrenia were examined. During the study, an analysis of patients’ outpatient and inpatient cards and psychodiagnostic scales for quantitative assessment of clinical, cognitive and social aspects patients’ life was carried out.

RESULTS AND CONCLUSION

The developed scale of treatment result complex assessment provides a personalized approach to the management of patients with paranoid schizophrenia. Such complex assessment of the patients’ mental state helps to optimize the analysis of the effects of various therapies, to simplify diagnostic tactics and to personalize the treatment algorithm.

Keywords:

schizophrenia

complex assessment

treatment result

Authors:

Samoylova D.D.

Razumovsky Saratov State Medical University

Barylnik Yu.B.

Razumovsky Saratov State Medical University

Received:

27.05.2019

Accepted:

23.09.2019

Close metadata

References:

Van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635–645. https://doi.org/10.1016/S0140-6736(09)60995-8
Mosolov SN. Actual theoretical problems of diagnostic, classification, neurobiology and therapy of schizophrenia: a comparison of International and Russian experience. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2010;110(6):4–11. (In Russ.).
Ovchinnikov AA, Zhdanok DN. Diagnostic approaches to social communication deficit in paranoid schizophrenia. Sibirskij vestnik psikhiatrii i narkologii. 2013;(1):86–90. (In Russ.).
Khritinin DF, Tsygankov BD, Semke VYa. Personologiya i psikhoterapiya: rukovodstvo dlya vrachej. Moscow: Meditsina; 2009. (In Russ.).
Zinchuk MS, Semke AV. Influence of negative symptoms on dynamic of social status of patients with paranoid schizophrenia. Sibirskij vestnik psikhiatrii i narkologii. 2013;(4):34–39. (In Russ.).
Zhdanok DN, Ovchinnikov AA, Semke AV. Kommunikativnye Paradoksy pri Rasstrojstvah shizofrenicheskogo Spektra. Moscow: Izdatel’skie resheniya; 2017. 146 p. (In Russ.).
Tarakanova EA, Kozhanov AV. Sovremennaya psikhofarmakoterapiya pri shizofrenii: sokhranenie zhizni bolnykh. Vestnik Akademii znanij. 2015;12(1):120–125. (In Russ.).
Samoylova DD, Barylnik JB. Variation of life quality and social functioning indication in patients with schizophrenia according to treatment response. V mire nauchnykh otkrytij. 2016;(7):47–60. (In Russ.). https://doi.org/10.12731/wsd-2016-7-3
Obukhov SG. Psikhiatriya. Moscow: Meditsina; 2007. (In Russ.).
Bekeneva LV, Balashov PP. Clinical and dynamic characteristic of paranoid schizophrenia outcomes. Sibirskij vestnik psikhiatrii i narkologii. 2012;(5):17–20. (In Russ.).
Samoilova DD, Barylnik YuB. Psycho-rehabilitation potential of schizophrenic patients on different medications. Sotsial’naya i klinicheskaya psikhiatriya. 2016;26(3):80–86. (In Russ.).
Altynbekov KS. Pharmacoeconomic aspects of schizophrenia treatment. Rossijskij psikhiatricheskij zhurnal. 2014;(6):51–55. (In Russ.).
Gurovich IYa, Shmukler AB, Zaytseva YuS. Dynamics of neurocognitive functioning in patients in early stages of schizophrenia and schizophrenia spectrum disorders. Zhurnal nevrologii i psikhiatrii. 2012;112(8):7–14. (In Russ.).
Plotnikov VV, Plotnikov DV. Cognitive performance in schizophrenic patients with different courses of disease. Sotsial’naya i klinicheskaya psikhiatriya. 2018;28(1):22–28. (In Russ.).
Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16(1):16–24. https://doi.org/10.1002/wps.20385
Rychkova OV, Silchouk EP. Social intelligence problems in schizophrenic patients. Sotsial’naya i klinicheskaya psikhiatriya. 2010;20(2):5–15. (In Russ.).
Gurovich IYa, Shmukler AB, eds. Psikhosotsial’naya i kognitivnaya terapiya i reabilitatsiya psikhicheski bol’nykh: prakticheskoe rukovodstvo. Moscow: Medpraktika-M; 2015. (In Russ.).
Pinkham AE, Hopfinger JB, Pelphrey KA, et al. The social cognition psychometric evaluation study: results of the expert servey and RAND panel. Schizophr Bull. 2014;40:813–823. https://doi.org/10.1093/schbul/sbt081
Cuevas C, Peñate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. Int J Clin Health Psychol. 2015;18(2):121–129. https://doi.org/10.1016/j.ijchp.2014.11.003